Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

2.
3.
4.

Oral contraceptive use and risk of colorectal cancer.

Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F.

Epidemiology. 1998 May;9(3):295-300.

PMID:
9583422
5.
6.

A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.

La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Lund E, Levi F, Linos D, Negri E.

Cancer Causes Control. 1999 Apr;10(2):157-66.

PMID:
10231164
7.

Interactions of familial and hormonal risk factors for large bowel cancer in women.

Newcomb PA, Taylor JO, Trentham-Dietz A.

Int J Epidemiol. 1999 Aug;28(4):603-8.

PMID:
10480684
8.
10.

Use of exogenous hormones hormones and risk of papillary thyroid cancer (Washington, United States).

Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR.

Cancer Causes Control. 1998 May;9(3):341-9.

PMID:
9684714
11.

Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.

Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.

Am J Epidemiol. 2007 May 15;165(10):1187-98. Epub 2007 Mar 3.

PMID:
17337757
12.

Colorectal cancer in northeast Italy: reproductive, menstrual and female hormone-related factors.

Franceschi S, Bidoli E, Talamini R, Barra S, La Vecchia C.

Eur J Cancer. 1991;27(5):604-8.

PMID:
1828971
14.

The influence of oral contraceptives on the risk of multiple sclerosis.

Thorogood M, Hannaford PC.

Br J Obstet Gynaecol. 1998 Dec;105(12):1296-9.

PMID:
9883921
15.

Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study.

Longstreth WT, Nelson LM, Koepsell TD, van Belle G.

Ann Intern Med. 1994 Aug 1;121(3):168-73.

PMID:
8017743
16.
17.

Hormonal factors and risk of lung cancer among women?

Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE.

Int J Epidemiol. 2003 Apr;32(2):263-71.

PMID:
12714547
18.

Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.

Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1212-8.

19.

Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.

Windler E, Zyriax BC, Eidenm├╝ller B, Boeing H.

Maturitas. 2007 Jul 20;57(3):239-46. Epub 2007 Feb 9.

PMID:
17292571
20.

Recent studies confirm the safety of oral contraceptives with respect to stroke.

[No authors listed]

Contracept Rep. 1996 Nov;7(4):4-9.

PMID:
12291813

Supplemental Content

Support Center